Notice Number:NOT-OD_09-058 Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications. Specific cross-talk between leptin and IL-1 signaling found in endometrial and breast cancer (BC) cells could be involved in their pro-angiogenic effects. It is hypothesized that the leptin-induced effects on breast cancer could occur upon leptin signaling the activation of MAPK and NFkB and, an increased expression of VEGF/VEGFR2, which may be linked to, or regulated, in part by IL-1 signaling. To test this hypothesis three Aims involving in vitro investigations in mouse (4T1, EMT6 and MMT) and human BC cells (MCF-7 and MDA-MB231) will be developed.
In Aim 1, leptin's regulatory mechanisms involved in IL-1 system expression (ligand, receptor and antagonist) will be investigated in mouse and human BC cells. To determine mechanisms of leptin-transcriptional regulation of IL-1 and IL-1R promoter-luciferase reporters (intact and site-directed mutagenesis for different transcription factors) will be used. ER expression and activation status relationships to leptin- IL-1 crosstalk will be analyzed in mouse and human BC cells.
In Aim 2, leptin regulation of IL-1 signaling intermediaries (i.e., MyD88, IRAK1, IRAK4 and TRAF6) and relationships between leptin-mediated activation of MAPK and MAP3 kinases (TAK1 and MEKK1) and JNK and P38 kinases related to IL-1 signaling will be investigated. Different vectors and ChIP assays will be used to study gene regulation of MyD88. ChIP assays and co-immunoprecipitation tests will be used to identify specific binding of leptin-activated transcription factors to MyD88 gene and to determine the extent of MyD88 homodimerization.
Aim 3 will investigate the molecular mechanism(s) involved in the leptin regulation of VEGF and VEGFR2 in breast cancer cells. While retaining the other binding regions for transcription factors, a series of VEGF promoter-reporter constructs with major cis-acting elements individually deleted will be used. To investigate the mechanisms of leptin regulation of VEGR2 luciferase constructs containing full-length of VEGFR2 promoter and truncated versions for AP2, NFkB binding deletions will be used. Data from these investigations will provide strong scientific basis to understand leptin-IL-1 crosstalk and to assess whether disruption of leptin-signaling could serve as a novel method for prevention/treatment of BC.
Results from these investigations would allow us to be a step closer to the potential translational use of inhibitoes [sic] of leptin signaling (PEG-LPrA) for prevention and/or treatment of BC that is highly important for obese and post-menopausal women. PEG-LPrA could be a useful biological agent or adjuvant to improve the efficacy of preventive/therapeutic regimens for BC.
| Colbert, Laronna S; Wilson, Kaamilah; Kim, Sungjin et al. (2014) NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer 14:249 |
| Battle, Monica; Gillespie, Corey; Quarshie, Alexander et al. (2014) Obesity induced a leptin-Notch signaling axis in breast cancer. Int J Cancer 134:1605-16 |
| Newman, Gale; Gonzalez-Perez, Ruben Rene (2014) Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol 382:570-582 |
| Gonzalez-Perez, Ruben Rene; Lanier, Viola; Newman, Gale (2013) Leptin's Pro-Angiogenic Signature in Breast Cancer. Cancers (Basel) 5:1140-62 |
| Guo, Shanchun; Liu, Mingli; Wang, Guangdi et al. (2012) Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta 1825:207-22 |
| Guo, Shanchun; Liu, Mingli; Gonzalez-Perez, Ruben R (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta 1815:197-213 |
| Zhou, W; Guo, S; Gonzalez-Perez, R R (2011) Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling. Br J Cancer 104:128-37 |
| Garonna, Elena; Botham, Kathleen M; Birdsey, Graeme M et al. (2011) Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLoS One 6:e18823 |
| Guo, Shanchun; Gonzalez-Perez, Ruben R (2011) Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS One 6:e21467 |
| Guo, Shanchun; Colbert, Laronna S; Fuller, Miles et al. (2010) Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta 1806:108-21 |
Showing the most recent 10 out of 12 publications
